Literature DB >> 3663157

Effect of adriamycin on heart mitochondrial DNA.

C N Ellis1, M B Ellis, W S Blakemore.   

Abstract

The effect of Adriamycin on rat heart mitochondrial DNA was determined by initially labelling the DNA with [Me-14C]thymidine. Animals subsequently received intravenously either Adriamycin (10 mg/kg) or saline (1 ml/kg) (control group). Animals later received [Me-3H]thymidine and were killed at 6, 14, 24 and 36 h after this. The heart mitochondrial DNA was separated into the linear, non-supercoiled and supercoiled forms by ultracentrifugation on formamide/sucrose sedimentation gradients, and the amount of 14C and 3H incorporated into the various forms of the DNA was determined by scintillation counting. The data suggest that Adriamycin may cause breakage of the mitochondrial DNA helix, and that it slows the rate of mitochondrial DNA synthesis and the formation of complete DNA molecules. These experiments show that Adriamycin does interact with heart mitochondrial DNA, and may explain the cardiac dysfunction association with Adriamycin use.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3663157      PMCID: PMC1148119          DOI: 10.1042/bj2450309

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Selective nicking of mammalian mitochondrial DNA in vivo: photosensitization by incorporation of 5-bromodeoxyuridine.

Authors:  R A Lansman; D A Clayton
Journal:  J Mol Biol       Date:  1975-12-25       Impact factor: 5.469

2.  Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents.

Authors:  J W Lown; S K Sim; K C Majumdar; R Y Chang
Journal:  Biochem Biophys Res Commun       Date:  1977-06-06       Impact factor: 3.575

3.  Mechanism of mitochondrial DNA replication in mouse L-cells: introduction of superhelical turns into newly replicated molecules.

Authors:  D Bogenhagen; D A Clayton
Journal:  J Mol Biol       Date:  1978-02-15       Impact factor: 5.469

4.  Molecular structural effects involved in the interaction of anthracyclines with DNA.

Authors:  F Zunino; A Di Marco; A Zaccara
Journal:  Chem Biol Interact       Date:  1979-02       Impact factor: 5.192

5.  Heart mitochondrial DNA synthesis: preferential inhibition by adriamycin.

Authors:  S C Hixon; C N Ellis; J P Daugherty
Journal:  J Mol Cell Cardiol       Date:  1981-09       Impact factor: 5.000

6.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

Review 7.  DNA gyrase and the supercoiling of DNA.

Authors:  N R Cozzarelli
Journal:  Science       Date:  1980-02-29       Impact factor: 47.728

8.  The interaction of daunorubicin and doxorubicin with DNA and chromatin.

Authors:  F Zunino; A Di Marco; A Zaccara; R A Gambetta
Journal:  Biochim Biophys Acta       Date:  1980-04-30

9.  Preferential alkylation of mitochondrial deoxyribonucleic acid by N-methyl-N-nitrosourea.

Authors:  V Wunderlich; M Schütt; M Böttger; A Graffi
Journal:  Biochem J       Date:  1970-06       Impact factor: 3.857

10.  Doxorubicin-induced congestive heart failure in adults.

Authors:  M M Haq; S S Legha; J Choksi; G N Hortobagyi; R S Benjamin; M Ewer; M Ali
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

View more
  8 in total

1.  PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy.

Authors:  Fereydoon Abedi-Gaballu; Gholamreza Dehghan; Maryam Ghaffari; Reza Yekta; Soheil Abbaspour-Ravasjani; Behzad Baradaran; Jafar Ezzati Nazhad Dolatabadi; Michael R Hamblin
Journal:  Appl Mater Today       Date:  2018-05-29

2.  Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin.

Authors:  O Marcillat; Y Zhang; K J Davies
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

3.  Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity.

Authors:  Salim Khiati; Ilaria Dalla Rosa; Carole Sourbier; Xuefei Ma; V Ashutosh Rao; Leonard M Neckers; Hongliang Zhang; Yves Pommier
Journal:  Clin Cancer Res       Date:  2014-04-08       Impact factor: 12.531

4.  Analysis of proteome changes in doxorubicin-treated adult rat cardiomyocyte.

Authors:  Suresh N Kumar; Eugene A Konorev; Deepika Aggarwal; Balaraman Kalyanaraman
Journal:  J Proteomics       Date:  2011-02-19       Impact factor: 4.044

5.  Intracellular localisation studies of doxorubicin and Victoria Blue BO in EMT6-S and EMT6-R cells using confocal microscopy.

Authors:  S M Burrow; D A Phoenix; M Wainwright; M J Tobin
Journal:  Cytotechnology       Date:  2002-05       Impact factor: 2.058

6.  Transcriptional role of p53 in interferon-mediated antiviral immunity.

Authors:  César Muñoz-Fontela; Salvador Macip; Luis Martínez-Sobrido; Lauren Brown; Joseph Ashour; Adolfo García-Sastre; Sam W Lee; Stuart A Aaronson
Journal:  J Exp Med       Date:  2008-07-28       Impact factor: 14.307

7.  Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling.

Authors:  N Ashley; J Poulton
Journal:  Oncogene       Date:  2009-08-17       Impact factor: 9.867

8.  Effect of adriamycin on DNA, RNA and protein biosyntheses in mouse tissues, in connection with its cardiotoxicity.

Authors:  Y Sazuka; H Tanizawa; Y Takino
Journal:  Jpn J Cancer Res       Date:  1989-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.